Ran Xiao

机构：Nanjing University of Chinese Medicine, China Pharmaceutical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Kanion Pharmaceutical (China) · ORCID：0000-0002-1359-4237

发表论文 66 篇 · 总被引 1576 次 · h-index 23

代表论文

• Comparison of concentrated fresh mononuclear cells and cultured mesenchymal stem cells from bone marrow for bone regeneration (2020 · Stem Cells Translational Medicine · 被引 31)
• A novel accurate volumetric analysis protocol for evaluating secondary alveolar cleft reconstruction (2020 · Journal of Cranio-Maxillofacial Surgery · 被引 22)
• Regenerative potential of pluripotent nontumorgenetic stem cells: Multilineage differentiating stress enduring cells (Muse cells) (2020 · Regenerative Therapy · 被引 21)
• Using network pharmacology to discover potential drugs for hypertrophic scars (2024 · British Journal of Dermatology · 被引 20)
• Comparison of image quality and lesion diagnosis in abdominopelvic unenhanced CT between reduced-dose CT using deep learning post-processing and standard-dose CT using iterative reconstruction: A prospective study (2021 · European Journal of Radiology · 被引 19)
• FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation (2025 · Communications Biology · 被引 18)